Please try another search
For the fiscal year ended 31 December 2021, Duchembio Co Ltd revenues decreased 46% to W10.98B. Net income totaled W1.52B vs. loss of W7.34B. Revenues reflect Other Finished Goods segment decrease of 91% to W380.2M, FDG segment decrease of 22% to W6.78B, South Korea segment decrease of 37% to W10.98B, Asia segment decrease of 100% to W5.2M. Net Income reflects Salaries & Wages decrease of 65% to W1.11B (expense), R & D Expense, Admin.
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 10984.82 | 20281.74 | 21777.64 | 22076.35 |
Gross Profit | 3200.6 | 4761.19 | 4817.8 | 4011.29 |
Operating Income | 451.74 | -5944.06 | -6711.47 | -3239.87 |
Net Income | 1519.69 | -7339.46 | -12296.3 | -8518.94 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 59986.16 | 25064.22 | 32784.76 | 33356.9 |
Total Liabilities | 39132.22 | 32719.5 | 33325.3 | 45505.69 |
Total Equity | 20853.94 | -7655.28 | -540.54 | -12148.79 |
Period Ending: | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | 1031 | -103.9 | 368.75 | 2381.19 |
Cash From Investing Activities | 482.16 | 837.6 | -2344.62 | -2915.8 |
Cash From Financing Activities | -359.56 | -965.78 | 913.56 | 1858.21 |
Net Change in Cash | 1153.61 | -233.67 | -1062.72 | 1323.57 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review